Product Images Lisdexamfetamine Dimesylate
View Photos of Packaging, Labels & Appearance
- 1 - 036 90
- 1 - 037 90
- 1 - 038 90
- 1 - 039 90
- 1 - 040 90
- 1 - 041 90
- 8c301747-figure-01 - lisdexamfetamine dimesylate capsules 1
- Figure 1 - lisdexamfetamine dimesylate capsules 2
- 2 - lisdexamfetamine dimesylate capsules 3
- 3 - lisdexamfetamine dimesylate capsules 4
- 1 - lisdexamfetamine dimesylate capsules 5
- figure 5 - lisdexamfetamine dimesylate capsules 6
- 6 - lisdexamfetamine dimesylate capsules 7
- 7 - lisdexamfetamine dimesylate capsules 8
- figure 8 - lisdexamfetamine dimesylate capsules 9
Product Label Images
The following 15 images provide visual information about the product associated with Lisdexamfetamine Dimesylate NDC 42291-041 by Avkare, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
1 - 036 90
1 - 037 90
1 - 038 90
1 - 039 90
1 - 040 90
1 - 041 90
8c301747-figure-01 - lisdexamfetamine dimesylate capsules 1
Figure 1 - lisdexamfetamine dimesylate capsules 2
2 - lisdexamfetamine dimesylate capsules 3
3 - lisdexamfetamine dimesylate capsules 4
1 - lisdexamfetamine dimesylate capsules 5
figure 5 - lisdexamfetamine dimesylate capsules 6
6 - lisdexamfetamine dimesylate capsules 7
7 - lisdexamfetamine dimesylate capsules 8
This text shows a graph with the title "Time (days after randomization)" and different data points. The data includes numbers such as "8" and percentages like "(%) 2iniies". Additionally, there are some unclear characters and symbols. This data may correspond to a study or experiment where measurements were taken over a period of days after randomization.*
figure 8 - lisdexamfetamine dimesylate capsules 9
This is a graph showing the proportion of subjects with relapse over time for those on Lisdexamfetamine dimesylate and Placebo in a clinical trial. The x-axis represents time in days after randomization, and the y-axis represents the percentage of subjects with relapse. The data suggests that Lisdexamfetamine dimesylate may have a lower relapse rate compared to the Placebo.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
